Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Mar 1;32(1):12-19.
doi: 10.53854/liim-3201-2. eCollection 2024.

Monkeypox virus infections in low-risk groups during the 2022-23 global outbreak: An analysis of the WHO global report

Affiliations
Review

Monkeypox virus infections in low-risk groups during the 2022-23 global outbreak: An analysis of the WHO global report

Max Carlos Ramírez-Soto et al. Infez Med. .

Abstract

Introduction: In the 2022-23 Mpox outbreak, cases also occurred in children, adolescents, and adults aged 50 years and older, for whom the risk of transmission is low and whose epidemiological characteristics are less known, compared to high-risk groups such as young adults. Here we describe the epidemiological characteristics of Mpox in children, adolescents and adults aged 50 years and older in the global Mpox outbreak.

Methods: A retrospective study on laboratory-confirmed surveillance data of Mpox cases reported to World Health Organization (WHO) was conducted. Case data from WHO's 2022-23 Mpox Outbreak: Global Trends from 1 January 2022 to 1 September 2023 was used for our analysis. We included cases reported by WHO with data on age (children [range, 0 to 9 years], adolescents [range, 10 to 17 years], adults 50 to 59 years, and adults 60 years and older), gender, WHO region, hospital admission, and intensive care unit admission.

Results: Until September 01, 2023, data from 89,752 cases of Mpox have been reported to WHO. Of all the reported cases, 1124 (1.3%), 6296 (7.0%) and 1501 (1.6%) were children and adolescents, adults aged 50-59 years, and adults aged 60 years or older, respectively, and the proportion varied among WHO regions. There was a high proportion of cases among population aged 0-17 years, adolescents (256 [66.3%]) from the region of the Americas and girls aged 0-9 years [127 (46.7%)] from the African region. Men aged 50-59 years (3495 [57.2%] vs. 2553 [41.8%] cases from the region of the Americas and the European region, respectively) and men aged 60-69 years (639 [60.0%] vs. 607 [48.4%] from the region of the Americas and the European region) were most affected, compared to other age groups and women. Among children, adolescents, and adults aged 50 years or older, a low proportion of cases developed some complications and required hospital admission, and some cases were admitted to the intensive care unit.

Conclusions: Epidemiological evidence of Mpox in these low-risk groups highlights the risk of wider community transmission. Therefore, while efforts continue to control the global outbreak of Mpox in high-risk groups, it is also necessary to ensure that these low-risk groups have access to timely health care and vaccination.

Keywords: Monkeypox; adults; children; epidemiology; older adults; outbreak.

PubMed Disclaimer

Conflict of interest statement

Declaration of competing interest: The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Global distribution of Mpox laboratory-confirmed cases and deaths among January 01, 2022 to September 01, 2023 (accessed on 01 September 2023) [7, 15].

Similar articles

  • Mpox in Children and Adolescents during Multicountry Outbreak, 2022-2023.
    Hoxha A, Kerr SM, Laurenson-Schafer H, Sklenovská N, Mirembe BB, Nezu IH, Ndumbi P, Fitzner J, Almiron M, Vila M, Pebody R, Vaughan AM, Haussig JM, de Sousa LA, Lukoya OC, Sanni OF, Nabeth P, Naiene JD, Kato M, Matsui T, Kuppalli K, Mala PO, Lewis RF, de Waroux OLP, Pavlin BI; WHO Mpox surveillance and Analytics Team. Hoxha A, et al. Emerg Infect Dis. 2023 Oct;29(10):2125-2129. doi: 10.3201/eid2910.230516. Epub 2023 Aug 30. Emerg Infect Dis. 2023. PMID: 37647121 Free PMC article.
  • Monkeypox (Mpox) outbreak during COVID-19 pandemic-Past and the future.
    Aden D, Zaheer S, Kumar R, Ranga S. Aden D, et al. J Med Virol. 2023 Apr;95(4):e28701. doi: 10.1002/jmv.28701. J Med Virol. 2023. PMID: 36951352 Review.
  • A global update of mpox (monkeypox) in children.
    Sam-Agudu NA, Martyn-Dickens C, Ewa AU. Sam-Agudu NA, et al. Curr Opin Pediatr. 2023 Apr 1;35(2):193-200. doi: 10.1097/MOP.0000000000001232. Epub 2023 Feb 22. Curr Opin Pediatr. 2023. PMID: 36809304 Review.
  • Mpox in people with past infection or a complete vaccination course: a global case series.
    Hazra A, Zucker J, Bell E, Flores J, Gordon L, Mitjà O, Suñer C, Lemaignen A, Jamard S, Nozza S, Nori AV, Pérez-Barragán E, Rodríguez-Aldama JC, Blanco JL, Delaugerre C, Turner D, Fuertes I, Leiro V, Walmsley SL, Orkin CM; SHARE-NET writing group. Hazra A, et al. Lancet Infect Dis. 2024 Jan;24(1):57-64. doi: 10.1016/S1473-3099(23)00492-9. Epub 2023 Sep 4. Lancet Infect Dis. 2024. PMID: 37678309
  • Mpox outbreak in France: epidemiological characteristics and sexual behaviour of cases aged 15 years or older, 2022.
    Krug C, Tarantola A, Chazelle E, Fougère E, Velter A, Guinard A, Souares Y, Mercier A, François C, Hamdad K, Tan-Lhernould L, Balestier A, Lahbib H, Etien N, Bernillon P, De Lauzun V, Durand J, Fayad M; Investigation Team; De Valk H, Beck F, Che D, Coignard B, Lot F, Mailles A; Investigation Team (alphabetically). Krug C, et al. Euro Surveill. 2023 Dec;28(50):2200923. doi: 10.2807/1560-7917.ES.2023.28.50.2200923. Euro Surveill. 2023. PMID: 38099346 Free PMC article.

Cited by

References

    1. Mitjà O, Ogoina D, Titanji BK, et al. M. Monkeypox. Lancet. 2023;401(10370):60–74. - PMC - PubMed
    1. Lum FM, Torres-Ruesta A, Tay MZ, et al. Monkeypox: disease epidemiology, host immunity and clinical interventions. Nat Rev Immunol. 2022;22(10):597–613. - PMC - PubMed
    1. Farahat RA, Sah R, El-Sakka AA, et al. Human monkeypox disease (MPX) Infez Med. 2022;30(3):372–391. - PMC - PubMed
    1. Ejaz H, Junaid K, Younas S, et al. Emergence and dissemination of monkeypox, an intimidating global public health problem. J Infect Public Health. 2022;15(10):1156–1165. - PMC - PubMed
    1. Bunge EM, Hoet B, Chen L, et al. The changing epidemiology of human monkeypox. A potential threat? A systematic review. PLoS Negl Trop Dis. 2022;16:e0010141. - PMC - PubMed

LinkOut - more resources